At Pear Bio, we monitor cancer progression of patient-derived tumor samples against potential treatment options.
Our organ-on-a-chip technology recreates core parts of the human tumor microenvironment for accurate testing. With the aid of our computer vision algorithms, we measure the impact each treatment has on stopping cancer in its tracks and removing the tumor.
We inform physicians to guide treatment decisions and we provide tools to help pharmaceutical companies develop new therapies.